Current Opinion in Gastroenterology
(ISSN: 0267-1379)
Show only: Full-text on Medscape
2009 - 25 (4)
- What is new in esophageal injury (infection, drug-induced, caustic, stricture, perforation)?
- Current world literature.
- Changes in screening, prognosis and therapy for esophageal adenocarcinoma in Barrett's esophagus.
- Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
- Achievements in esophagology during 2008.
- What's new in the diagnosis and therapy of eosinophilic esophagitis?
- Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
- Making therapeutic decisions in inflammatory bowel disease: the role of patients.
- Immunosuppression in inflammatory bowel disease: traditional, biological or both?
- Evolving issues in the management of reflux disease?
- The evolving epidemiology of inflammatory bowel disease.
- Pouchitis: lessons for inflammatory bowel disease.
- What is left of the endoscopic antireflux devices?
